Bemarituzumab
FPA144-004 Phase 1
Phase 1 mab completed
Quick answer
Bemarituzumab for Gastrointestinal Cancer is a Phase 1 program (mab) at Prime Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Prime Medicine
- Indication
- Gastrointestinal Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- completed